Overview
Status
Active
Registry date
2023-10-04
Share capital
5,000.00 PLN
Registered address
ul. Franciszka Żwirki I Stanisława Wigury 15, 38-400 Krosno, Poland
Electronic delivery address
AE:PL-90277-77122-RVHDA-22
Financials
Revenue history
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 3 financial statements was filed late (for 2023, 1 day late).
- 2025filed
- 202430/06/2025
- 202316/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 393.83MedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -61.08kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 61.30kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 36.60kMedianUSD 883.09kAverageUSD 31.39m
Industry
Authorized Representatives
Anna Stanisława Siwiec – President of the Management Board
Michał Kiełtaczyński – Vice President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Michał Kiełtaczyńskiage 32 | 25 | $675.31 | 50% |
Anna Stanisława Siwiecage 50 | 25 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-10-17.
04 1050 1562 1000 0090 8286 4654
79 1050 1562 1000 0090 8286 4662
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 4, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $54,025$54,025 | Podkarpackie Centrum Innowacji sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
FAQ
The main business activity of Heliscreen focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on October 4, 2023.
The headquarters is located at: ul. Franciszka Żwirki I Stanisława Wigury 15, 38-400 Krosno.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $357 in 2024, which is an increase of 1467.7% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $15,562. For comparison, in 2023 the loss was $1,974, meaning the company increased its loss by 648.8%.
The largest operating cost category falls under external services. This category amounted to $13,821 in 2024, representing 95% of all operating expenses.
Last updated: 2026-10-07